e-learning
resources
Stockholm 2002
Monday 16.09.2002
Mesothelioma and malignant pleural effusion
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The reliability of the cytological diagnosis malignant mesothelioma
J. G. Aerts, M. Delahaye, T. van der Kwast, H. C. Hoogsteden, J. P. van Meerbeeck (Rotterdam, The Netherlands)
Source:
Annual Congress 2002 - Mesothelioma and malignant pleural effusion
Session:
Mesothelioma and malignant pleural effusion
Session type:
Thematic Poster Session
Number:
1739
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. G. Aerts, M. Delahaye, T. van der Kwast, H. C. Hoogsteden, J. P. van Meerbeeck (Rotterdam, The Netherlands). The reliability of the cytological diagnosis malignant mesothelioma. Eur Respir J 2002; 20: Suppl. 38, 1739
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Diagnosis and staging of malignant pleural mesothelioma
Related content which might interest you:
Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006
Diagnosis of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004
Quick immunohistochemical diagnosis of neoplasia pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 581s
Year: 2006
Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009
Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004
Cytological diagnosis of malignant mesothelioma – improvement by additional determination of hyaluronic acid in pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 783s
Year: 2006
Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
An audit of the use of Abrams‘ pleural biopsy in the diagnosis of mesothelioma
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Thoracoscopy and malignant pleural mesothelioma
Source: ERS Course 2015
Year: 2015
Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007
Diagnosis of malignant pleural mesothelioma: the clinician and pathologist points of view
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009
Diagnostic problems in benign and malignant pleural effusions
Source: Annual Congress 2007 - PG16 - Management of pleural problems in your practice today
Year: 2007
The importance of radiological findings to distinguish benign and malignant pleural diseases
Source: Annual Congress 2008 - Imaging and measurement techniques in the evaluation of pulmonary embolism, COPD and pleural diseases
Year: 2008
Biochemical and cytological features of metastatic pleural effusions in breast cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007
Prognostic characteristics of malignant pleural mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept